CD Genomics proprietary GenSeqTM Technology provides the universal biological materials in area of disease diagnoses and scientific researches. CD Genomics has worked relentlessly in applying NGS to FFPE samples.
We expect that NGS technologies with Formalin-fixed, paraffin-embedded (FFPE) samples will substantially facilitate our understanding of undefined pathological mechanisms and broaden our insights in biomedical research.
Millions of archival FFPE samples provide an enormous and invaluable repository of information for genotyping studies. FFPE samples are preserved tissue samples that are generally associated with disease. These samples hold a wealth of data for biomarker discovery, drug development, and cancer research.
However, formidable challenging to get intact information from such samples, as severe degradation, or chemical modification could occur during sample preparation and store process. There are quite few usages of next generation sequencing (NGS) method in deciphering the FFPE nucleotide information. In order to unveil the information concealed in FFPE samples. To overcome this problem, the FFPE sample restoration solution provides a simple workflow to QC samples, repair damaged DNA, and achieve high-quality data.
Low input: As low as 200ng as for WGS, WES and RNA-Seq.
High throughput: Millions of reads product for downstream analysis.
Special analysis: Bioinformatics contents only for cancer tissue.
On the GenSeqTM Technology, expression data from RNA purified from FFPE samples is highly correlated with data from RNA matched fresh samples. Furthermore, the capability of CD Genomics make our FFPE Samples Sequencing ideal for various types of clinical research studies and signature development, especially in cancer research.